Although the deal has not yet been formally announced, Apple (NASDAQ: AAPL ) is still expected to acquire Beats Electronics at some point in the near future. Much has already been written about the purchase -- its potential to bring a level of fashion to Apple's future wearables, Beats co-founder Jimmy Iovine's music industry experience -- but what I find most interesting is what it says about Apple's iTunes business.
Apple's total iTunes revenue is growing, and at a rapid pace, but the model on which the business was built -- music downloads -- could slow. Streaming services are clearly the future, and though acquiring Beats should help Apple break into that business, it still poses a major challenge.
Downloads give way to subscriptions
Industry music downloads slipped 5.7% on an annual basis last year, according to Nielsen. Consistent with those figures, Asymco estimated that Apple's iTunes Music sales declined about 14% in 2013.
It's possible that a lack of quality music may have weighed on iTunes' sales last year (arguably, fewer must-have songs were released in 2013), but the growth of music subscription services cannot be discounted. Spotify, the leader in that business, now has 10 million paying subscribers, up from just 5 million 17 months ago.
10 Best New Stocks For 2015: Thoratec Corporation(THOR)
Thoratec Corporation engages in the development, manufacture, and marketing of proprietary medical devices used for circulatory support. The company?s primary product lines include ventricular assist devices, such as HeartMate II, an implantable left ventricular assist device consisting of a rotary blood pump to provide intermediate and long-term mechanical circulatory support (MCS); and HeartMate XVE, an implantable and pulsatile left ventricular assist device for intermediate and longer-term MCS. Its ventricular assist devices also comprise Paracorporeal Ventricular Assist Device, an external pulsatile ventricular assist device, which provides left, right, and biventricular MCS approved for bridge-to-transplantation (BTT), including home discharge, and post-cardiotomy myocardial recovery; and Implantable Ventricular Assist Device, an implantable and pulsatile ventricular assist device designed to provide left, right, and biventricular MCS approved for BTT comprising hom e discharge, and post-cardiotomy myocardial recovery. The company also provides CentriMag, an extracorporeal full-flow acute surgical support platform that offers support up to 30 days for cardiac and respiratory failure. In addition, it offers PediMag and PediVAS extracorporeal full-flow acute surgical support platforms designed to provide acute surgical support to pediatric patients. The company sells its products through direct sales force in the United States, as well as through a network of distributors internationally. Thoratec Corporation was founded in 1976 and is headquartered in Pleasanton, California.
Advisors' Opinion:- [By Anna Prior]
Medical device company Thoratec Corp.(THOR) has purchased Apica Cardiovascular Ltd., in a deal that includes $35 million in cash upfront and potential milestone payments of up to $40 million.
- [By Ali Berri]
In trading on Thursday, healthcare shares were relative laggards, down on the day by about 0.62 percent. Meanwhile, top decliners in the sector included Thoratec (NASDAQ: THOR), down 28.4 percent, and PhotoMedex (NASDAQ: PHMD), off 14.6 percent.
Top Growth Stocks To Invest In 2014: MEDIFAST INC(MED)
Medifast, Inc., through its subsidiaries, engages in the production, distribution, and sale of weight management and disease management products, and other consumable health and diet products in the United States. The company?s product lines include weight and disease management, meal replacement, and vitamins. It also operates weight control centers that offer Medifast programs for weight loss and maintenance, customized patient counseling, and inbody composition analysis. The company markets its products under the Medifast and Essential brand names, including shakes, appetite suppression shakes, women?s health shakes, diabetics shakes, joint health shakes, coronary health shakes, calorie burn drinks, calorie burn flavor infusers, antioxidant shakes, antioxidant flavor infusers, bars, crunch bars, soups, chili, oatmeal, pudding, scrambled eggs, hot cocoa, cappuccino, chai latte, iced teas, fruit drinks, pretzels, puffs, brownie, pancakes, soy crisps, crackers, and omega 3 and digestive health products. Medifast Inc. sells its products through various channels of distribution comprising Web, call center, independent health advisors, medical professionals, weight loss clinics, and direct consumer marketing supported via the phone and the Web; Take Shape for Life, a physician led network of independent health coaches; and weight control centers. The company was founded in 1980 and is headquartered in Owings Mills, Maryland.
Advisors' Opinion:- [By Holly LaFon] ast produces, distributes and sells weight and health management products with the brand names Medifast, Take Shape for Life, Hi-Energy Weight Control Centers and Woman�� Wellbeing.
Its return on assets in the third quarter of 2011 was 19.6%, which has been increasing in the past several years. The average return on assets for the specialty retail industry is 10.48% for the trailing 12 months.
The company�� total assets amounted to $94 million in 2010, which increased from $62.8 million in 2009. Net income also increased to $19.6 million in 2010 from $12 million in 2009.
Boston Beer Inc. (SAM)
Boston Beer Inc. is the largest brewer of handcrafted beers in America. Boston Beer is a growing company that recently saw a large increase in its return on assets. It increased from 19.3% in 2010 to 29.7% in 2011, and was negative as recently as 2008. The average return on assets for the beverages industry in the trailing 12 months is 9.47%.
In 2011, the company�� total assets increased to $272.5 million from $258.5 million in 2010. Net income increased to $66 million from $50 million.
Alliances Resources Partners (ARLP)
Alliance Resources Partners is a coal producer and marketer primarily in the eastern U.S. Its ROA has been increasing since 2008 and increased to 22.5% in 2011 from 21.4% in 2010. The average return on assets for the oil, gas & consumable fuels industry in the trailing 12 months is 24.47%.
In 2011, its total assets increased to $1.7 billion from $1.1 billion in 2010. Its net income increased to $389 million from $321 million.
Factset Research Systems Inc. (FDS)
Factset researches global market trends and develops analytical tools for investors. Of all of GuruFocus��5-star predictable companies, it has the highest return on assets at 27%. ROA has been increasing over the past several years. The average return on assets for the software industry for the trailing 12 m
- [By Robert Hanley]
Consumer-goods marketer Blyth (NYSE: BTH ) , owner of weight-loss upstart ViSalus, has been in the doghouse lately, sitting near a 52-week low due to poor results in its weight-loss unit.� Despite a large potential customer base of overweight people worldwide, the industry has had difficulty generating growth lately, with data provider Marketdata Enterprises estimating that industry sales rose only 1.7% in 2012.� However, Blyth caught a bid in late October from a proposed combination with marketing-services provider CVSL, indicating that some people see incremental value in Blyth's businesses.�So, should small investors bet on this small cap or should they focus their attention on Weight watchers International (NYSE: WTW ) and Medifast (NYSE: MED ) instead?
- [By Ali Berri]
In trading on Friday, non-cyclical consumer goods & services shares were relative laggards, down on the day by about 0.09 percent. Meanwhile, top decliners in the sector included Medifast (NYSE: MED), down 9.6 percent, and Universal (NYSE: UVV), off 3.9 percent.
- [By Monica Gerson]
Medifast (NYSE: MED) is expected to post its Q4 earnings at $0.36 per share on revenue of $80.83 million.
Full House Resorts (NASDAQ: FLL) is estimated to post a Q4 loss at $0.06 per share on revenue of $33.24 million.
Top Growth Stocks To Invest In 2014: Intuitive Surgical Inc.(ISRG)
Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems for various surgical procedures, including urologic, gynecologic, cardiothoracic, general, and head and neck surgeries. Its da Vinci surgical system consists of a surgeon?s console or consoles, a patient-side cart, a 3-D vision system, and proprietary ?wristed? instruments. The company?s da Vinci surgical system translates the surgeon?s natural hand movements on instrument controls at the console into corresponding micro-movements of instruments positioned inside the patient through small puncture incisions, or ports. It also manufactures a range of EndoWrist instruments, which incorporate wrist joints for natural dexterity for various surgical procedures. Its EndoWrist instruments consist of forceps, scissors, electrocautery, scalpels, and other surgical tools. In addition, it sells various vision and accessory products for use in conjunction with the da Vinci Surgical System as surgical procedures are performed. The company?s accessory products include sterile drapes used to ensure a sterile field during surgery; vision products, such as replacement 3-D stereo endoscopes, camera heads, light guides, and other items. It markets its products through sales representatives in the United States, and through sales representatives and distributors in international markets. The company was founded in 1995 and is headquartered in Sunnyvale, California.
Advisors' Opinion:- [By Jake L'Ecuyer]
Shares of Intuitive Surgical (NASDAQ: ISRG) got a boost, shooting up 8.83 percent to $476.67 after the company announced the FDA clearance and U.S. introduction of the new da Vinci Xi Surgical System.
- [By Ben Levisohn]
JPMorgan Chase (JPM) dropped 7.5% to $55.30 this week–making it the Dow’s big loser–after missing earnings forecasts, while Pfizer (PFE) dropped 7.2% to $29.86. Intuitive Surgical (ISRG) plummeted 13% to $439.63 after it said it miss first-quarter revenue forecasts. AbbVie (ABBV), meanwhile, plunged 11% to $46.46 after Merck’s (MRK) competing hepatitis C drug worked well in a trial. Merck fell 0.4% to $55.92 this week.
- [By Matt Thalman]
Two other big Dow winners came from the health-care industry as Johnson & Johnson (NYSE: JNJ ) rose 2.28% and Pfizer (NYSE: PFE ) gained 2.11%. Johnson & Johnson reported earnings earlier in the week and the company beat on both the top and bottom lines, but after earnings were announced, shares closed even on Tuesday, compared to Monday's close, at $90.40. While investors surely liked the fact that estimates had been topped, they didn't seem to be thrilled with some comments by management that pricing pressure was increasing. But�a poor earnings report, an FDA warning, and weak guidance moving forward from Intuitive Surgical (NASDAQ: ISRG) yesterday�make Johnson & Johnson's medical device unit look stronger than ever. And that's why I believe shares of J&J moved higher today.
- [By Sean Williams]
This, I proposed earlier this week, could be the reasoning behind weaker sales of the Intuitive Surgical's (NASDAQ: ISRG ) da Vinci robotic surgical system. The robotic soft tissue surgical device tends to be costlier than standard laparoscopic procedures, but can reduce hospital stays compared to traditional surgery, possibly making it a cheaper overall option for some people. The device itself, though, costs well beyond $1.5 million, which is a cost that many hospitals would rather not endure with so many question marks still surrounding Obamacare. All told, Intuitive sold just 143 of its devices in the U.S. this quarter compared to 150 last year.
Top Growth Stocks To Invest In 2014: Eastern Insurance Holdings Inc.(EIHI)
Eastern Insurance Holdings, Inc., through its subsidiaries, provides workers compensation insurance and reinsurance products in the United States. The company?s Workers Compensation Insurance segment provides traditional workers compensation insurance coverage products, including guaranteed cost policies, policyholder dividend policies, retrospectively-rated policies, deductible policies, and alternative market products to employers. This segment distributes its workers? compensation products and services through its independent insurance agents primarily in Pennsylvania, Delaware, North Carolina, Maryland, Indiana, and Virginia. Its Segregated Portfolio Cell Reinsurance segment offers alternative market workers compensation solutions comprising program design, fronting, claims administration, risk management, segregated portfolio cell rental, asset management, and segregated portfolio management services to individual companies, groups, and associations. Eastern Insurance Holdings, Inc. is headquartered in Lancaster, Pennsylvania.
Advisors' Opinion:- [By Lauren Pollock]
ProAssurance Corp.(PRA) agreed to acquire Eastern Insurance Holdings Inc.(EIHI) for about $205 million, expanding the insurance company’s casualty insurance offerings. Eastern Insurance is a domestic casualty insurance group specializing in workers’ compensation products and services, among other things. ProAssurance plans to pay $24.50 in cash for each outstanding Eastern share, a 16% premium over Monday’s closing price.
No comments:
Post a Comment